ArticleHaematologica2023

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.

Naranie Shanmuganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.